Although the exact mechanism whereby CD44+ cancer cells stimulate OPN secretion is not clear, this study suggests that, despite strongly relying on their niche, CSCs can reprogram stromal cells (e.g., TAMs) so that the latter can gain a growth advantage. Here, CD44 is linked to cancer.